A common variant association study in ethnic Saudi Arabs reveals novel susceptibility loci for hypertriglyceridemia
暂无分享,去创建一个
G. Morahan | N. Dzimiri | B. Meyer | N Dzimiri | G Morahan | R Ram | S M Wakil | N P Muiya | E Andres | N Mazhar | S Hagos | M Alshahid | B F Meyer | S. Wakil | E. Andres | Samya T. Hagos | B. Meyer | R. Ram | M. Alshahid | N. Mazhar | S.M. Wakil | N.P. Muiya | S. Hagos | Editha Andres | Nzioka P. Muiya | Nejat Mazhar
[1] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[2] Ying Liu,et al. FaST linear mixed models for genome-wide association studies , 2011, Nature Methods.
[3] C. Shoulders,et al. Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[4] J. Liepnieks,et al. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. , 1988, Biochemical and biophysical research communications.
[5] Hae-Young Lee,et al. Aging and arterial stiffness. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[6] R. Iqbal,et al. Genetic association of lipid metabolism related SNPs with myocardial infarction in the Pakistani population , 2014, Molecular Biology Reports.
[7] A. Ghasemi,et al. C771G (His241Gln) Polymorphism of MLXIPL Gene, TG levels and coronary artery disease: A case control study , 2014, Anatolian journal of cardiology.
[8] W.‐C. Lee. Testing the Genetic Relation Between Two Individuals Using a Panel of Frequency‐unknown Single Nucleotide Polymorphisms , 2003, Annals of human genetics.
[9] S. Eyheramendy,et al. APOA5 Q97X Mutation Identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family , 2012, BMC Medical Genetics.
[10] V. Salomaa,et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia , 2010, Nature Genetics.
[11] N. Timpson,et al. Association of Common Genetic Variants with Lipid Traits in the Indian Population , 2014, PloS one.
[12] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[13] R. Collins,et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.
[14] S. Yusuf,et al. Polygenic determinants of severe hypertriglyceridemia. , 2008, Human molecular genetics.
[15] Zhiming Huang,et al. A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis , 2014, Lipids in Health and Disease.
[16] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[17] Xiaojun Tang,et al. Association study of genetic variants at newly identified lipid gene TRIB1 with coronary heart disease in Chinese Han population , 2015, Lipids in Health and Disease.
[18] S. Humphries,et al. The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes , 2014, Current opinion in lipidology.
[19] J. Lupski,et al. Whole-Exome Sequencing Reveals GPIHBP1 Mutations in Infantile Colitis With Severe Hypertriglyceridemia , 2014, Journal of pediatric gastroenterology and nutrition.
[20] G. Cui,et al. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. , 2014, Journal of the American College of Cardiology.
[21] S. Yusuf,et al. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia , 2009, Human molecular genetics.
[22] Päivi Pajukanta,et al. Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci , 2013, Journal of Medical Genetics.
[23] R. Hegele,et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia , 2012, Journal of internal medicine.
[24] P. Pajukanta,et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia , 2007, Nature Genetics.
[25] R. Hegele,et al. Genetic bases of hypertriglyceridemic phenotypes , 2011, Current opinion in lipidology.
[26] F. Azizi,et al. Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study , 2015, British Journal of Nutrition.
[27] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[28] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[29] E. Boerwinkle,et al. Association of rs780094 in GCKR with Metabolic Traits and Incident Diabetes and Cardiovascular Disease: The ARIC Study , 2010, PloS one.
[30] C. Bauters,et al. [Pathophysiology of coronary artery disease]. , 2008, La Revue du praticien.
[31] P. Hawkins,et al. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Hokanson,et al. Lipoprotein lipase gene sequencing and plasma lipid profile[S] , 2014, Journal of Lipid Research.
[33] Tanya M. Teslovich,et al. Common variants associated with plasma triglycerides and risk for coronary artery disease , 2013, Nature Genetics.
[34] Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis , 2013, Molecular Biology Reports.
[35] S. Kathiresan,et al. Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.
[36] K. Kohara,et al. The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population , 2010, Journal of Human Genetics.
[37] R. Gregg,et al. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. , 1990, Genomics.
[38] J. Klovins,et al. Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population , 2014, Meta gene.
[39] S. Humphries,et al. Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations , 2014, Journal of Medical Genetics.
[40] T. Ando,et al. Association of the GCKR rs780094 polymorphism with metabolic traits including carotid intima-media thickness in Japanese community-dwelling men, but not in women , 2014, Clinical chemistry and laboratory medicine.
[41] G. Can,et al. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[42] Yun Liu,et al. Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population[S] , 2011, Journal of Lipid Research.
[43] E. Lefai,et al. An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. , 2014, American journal of human genetics.
[44] R. Mateo-Gallego,et al. Common Genetic Variants Contribute to Primary Hypertriglyceridemia Without Differences Between Familial Combined Hyperlipidemia and Isolated Hypertriglyceridemia , 2014, Circulation. Cardiovascular genetics.
[45] D. Meyre,et al. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children , 2017, Pediatric obesity.
[46] Dolores Corella,et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.
[47] Association of the MLXIPL/TBL2 rs17145738 SNP and serum lipid levels in the Guangxi Mulao and Han populations , 2013, Lipids in Health and Disease.
[48] Y. Tsai,et al. Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster , 2013, Nutrition & Diabetes.
[49] L. Wilkins. Functional Analysis of the TRIB1 Associated Locus Linked to Plasma Triglycerides and Coronary Artery Disease , 2016, Journal of the American Heart Association.
[50] R. Fresa,et al. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[51] D. Booth,et al. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. , 1994, The Quarterly journal of medicine.
[52] Inês Barroso,et al. Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[53] T. Nielsen,et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes , 2007, Diabetologia.
[54] A. Hofman,et al. Low-density lipoprotein receptor mutations generate synthetic genome-wide associations , 2012, European Journal of Human Genetics.
[55] M. Taskinen,et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. , 2009, The Journal of clinical endocrinology and metabolism.
[56] F. Hu,et al. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population , 2009, Diabetologia.
[57] P. D. de Bakker,et al. Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease , 2014, PloS one.
[58] D. Heckerman,et al. Further Improvements to Linear Mixed Models for Genome-Wide Association Studies , 2014, Scientific Reports.
[59] J. Hubacek,et al. Association of metabolic and genetic factors with cholesterol esterification rate in HDL plasma and atherogenic index of plasma in a 40 years old Slovak population. , 2011, Physiological research.
[60] B. Melegh,et al. Triglyceride level modifying functional variants of GALTN2 and MLXIPL in patients with ischaemic stroke , 2010, European journal of neurology.